Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH)
dc.contributor.author | Kabacam, Gokhan | |
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Heidrich, Benjamin | |
dc.contributor.author | Yalcin, Kendal | |
dc.contributor.author | Onder, Fatih Oguz | |
dc.contributor.author | Dienes, Hans P. | |
dc.contributor.author | Manns, Michael P. | |
dc.date.accessioned | 2024-04-24T17:49:55Z | |
dc.date.available | 2024-04-24T17:49:55Z | |
dc.date.issued | 2012 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 393A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.startpage | 392A | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/23087 | |
dc.identifier.volume | 56 | en_US |
dc.identifier.wos | WOS:000310955601407 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Wiley-Blackwell | en_US |
dc.relation.ispartof | Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH) | en_US |
dc.title | Implications of HBsAg, HBcAg and HDAg Immunohistochemistry in Course and Treatment of Chronic Delta Hepatitis (CDH) | |
dc.type | Conference Object | en_US |